Sulfamic Acid → 2-(5-methoxy-1-methyl-1H-indazol-3-yl)-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid

関与物質

反応条件

反応手順

To a yellow suspension of 2-(5-methoxy-1-methyl-1H-indazol-3-yl)-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carbaldehyde (443 mg, 1.01 mmol) in dioxane (14 mL) and water (4 mL) at 0° C. was added sulfamic acid (590 mg, 6.07 mmol, Eq: 6.00), followed by drop-wise addition of a solution of sodium chlorite (149 mg, 1.32 mmol) and KH2PO4 (1.65 g, 12.1 mmol2.00) in water (4.5 mL) via dropping funnel over 15 min. The ice bath was removed and the light yellow suspension was stirred at 25° C. for 18 h. LCMS indicated reaction about 50% complete, THF (10 mL) added to the yellow suspension then addition at 25° C. of more reagents: sulfamic acid (590 mg, 6.07 mmol, Eq: 6.00) solid, followed by a dropwise addition of a solution of sodium chlorite (149 mg, 1.32 mmol) and KH2PO4 (1.65 g, 12.1 mmo12.00) in 10 mL of water and stirring continued at 25° C. for 4 h. Mixture diluted with water (50 mL) and extracted with dichloromethane (3×40 mL). The combined organic layers were dried (MgSO4), added some charcoal heated to reflux, after cooling down to 25° C., filtered over a celite pad and evaporated. Light yellow solid residue was dissolved in dichloromethane/MeOH and dichloromethane evaporated to promote solid formation, solid separated by filtration, rinsed with MeOH and hexanes and dried to give 2-(5-methoxy-1-methyl-1H-indazol-3-yl)-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (238 mg, 525 μmol, 51.8%). MS (M+H)+=454 (>90% purity); 1H NMR (CDCl3) δ: 9.38 (s, 1H), 8.38 (s, 1H), 7.92 (d, J=2.6 Hz, 1H), 7.41 (d, J=9.1 Hz, 1H), 7.19 (dd, J=9.3, 2.5 Hz, 1H), 5.79 (s, 2H), 4.21 (s, 3H), 3.99 (s, 3H), 3.60-3.73 (m, 2H), 0.93-1.06 (m, 2H), 0.00 (s, 9H).

情報源と証拠